FDA Gets Message In Congress' First Cannabis Policy Hearing: Deliver CBD Regulation

During first-ever congressional hearing on federal policies for lawful use of cannabis, House Energy and Commerce Health Subcommittee Chairwoman Anna Eschoo says with $2m appropriated to develop a regulation on CBD’s use in non-drug products during, FDA should deliver.

Time for action

The US Food and Drug Administration’s three- to five-year estimate for a rulemaking on lawful use of cannabidiol in dietary supplements rattled a House subcommittee chairwoman already disappointed in the agency’s oversight of the exploding market.

“FDA says it will take three to five years to finalize CBD regulations and in the meantime the CBD market is predicted to reach $20bn in sales by 2024

More from Legislation

More from Policy & Regulation